Provided by: Chunghwa Chemical Synthesis & Biotech Co.,Ltd
SEQ_NO
6
Date of announcement
2022/05/25
Time of announcement
17:52:28
Subject
The Board of Directors resolved to appoint the 5th Term
Remuneration Committee member.
Date of events
2022/05/25
To which item it meets
paragraph 6
Statement
1.Date of occurrence of the change:2022/05/25
2.Name of the functional committees:remuneration committee
3.Name of the previous position holder:
WANG ,KUO-CHIANG
TSAI ,CHUNG-HSIEN
CHANG ,CHIH-HSIEN
4.Resume of the previous position holder:
WANG ,KUO-CHIANG：The company Independent Director
TSAI ,CHUNG-HSIEN：The company Independent Director
CHANG ,CHIH-HSIEN：The company Independent Director
5.Name of the new position holder:
WANG ,KUO-CHIANG
CHANG ,CHIH-HSIEN
KUAN ARTHUR
6.Resume of the new position holder:
WANG ,KUO-CHIANG：The company Independent Director
CHANG ,CHIH-HSIEN：The company Independent Director
KUAN ARTHUR：Chairman, Allied Industrial Corp., Ltd.
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):tenure expired
8.Reason for the change:Tenure expired,Re-election of directors
9.Original term (from __________ to __________):2019/05/31~2022/05/30
10.Effective date of the new member:2022/05/25
11.Any other matters that need to be specified:
The tenure of the Remuneration Committee is the same as the tenure
of Board of Directors.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Chunghwa Chemical Synthesis & Biotech Co. Ltd. published this content on 25 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 May 2022 16:12:02 UTC.
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. is a Taiwan-based company principally engaged in the manufacture and distribution of biotechnology products and chemical synthetic products. The Company's biotechnology products include pravastatin, rapamycin, tacrolimus, everolimus, mycophenolate mofetil, mycophenolic acid sodium and others. Its non-biotechnology products include methocarbamol, guaifenesin, trandolapril, fluconazole, olopatadine, dexbromopheniramine maleate and glipizide, among others. Its products are applied in the manufacture of drugs for treatment of cough, diabetes, cardiovascular diseases, high blood pressure and immune system diseases. The Company distributes its products within domestic market and to overseas markets, including the rest of Asia, the Americas and Europe.
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. 
